International Symposium on Cancer Immunotherapy: Featuring Today's Innovators, Tomorrow's Leaders
The SITC 2015 Presentation Archive is supported through a generous contribution from AstraZeneca/MedImmune.
Access slide decks and video via the links in the schedule below.
= PDF of slides is available
= Presentation video is available
Program Schedule
Wednesday, November 4, 2015
| 2 p.m. – 2:05 p.m. | Welcome and Introductions Bernard A. Fox, PhD - Society for Immunotherapy of Cancer |
Session I: Target |
|
|
Co-Chairs |
|
| 2:05 p.m. – 2:25 p.m. | Toward Personalized Immunotherapy for Lymphoma: Identification of Common Driver Mutations Recognized by Patient T Cells Julie Nielsen, PhD – Canadian Cancer Immunotherapy Consortium (CCIC) |
| 2:25 p.m. – 2:45 p.m. | Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen Encoded by an Alternative ITGB2 Transcript Margot J. Pont, MSc – Dutch Tumor Immunology Working Party (DTIWP) |
| 2:45 p.m. – 3:05 p.m. | Diagnostic Solution Improvement by Immunohistochemistry Analysis of Metastatic Melanoma Liver Core Biopsies, Selected by Magnetic Resonance Imaging Gyorgy Naszados, MD – National Institute of Oncology, Budapest, Hungary |
| 3:05 p.m. – 3:25 p.m. | Role of the Calcium Binding GPRC6a Receptor in Chemotherapy Mediated Immunogenic Cell Death Induced Tumor Control rer. Nat Dagmar Quandt, PhD – AKTuI - Arbeitskreis Tumorimmunologie (German Cancer Immunology group in the German Immunology Society) with Tumor Immunology Meets Oncology (TIMO) |
| 3:25 p.m. – 3:35 p.m. | Break |
Session II: Escape |
|
|
Co-Chairs |
|
| 3:35 p.m. – 3:55 p.m. | Role of Melanoma Exosomes in Pro-Tumor Conversion of Immune Cells Chiara Camisaschi, PhD – Cancer Drug Development Forum (CDDF) |
| 3:55 p.m. – 4:15 p.m. | T Cell Exhaustion in Leukemia relapse Post Allogeneic Stem Cell Transplantation Hong Zheng, MD, PhD – Chinese American Hematologist and Oncologist Network (CAHON) |
| 4:15 p.m. – 4:35 p.m. | Regulatory T Cell-Mediated Anergy Induction in Tumor-self Antigen-Specific CD8+ T Cells Yuka Maeda, PhD – Japanese Association of Cancer Immunology (JACI) |
| 4:35 p.m. – 4:55 p.m. | Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies Amir A. Al-Khami, PhD – Tumor Vaccine and Cell Therapy Working Group (TVACT) |
| 4:55 p.m. – 5:40 p.m. | Working Dinner Break |
Session III: Monitoring |
|
|
Co-Chairs |
|
| 5:40 p.m. – 6 p.m. | Dynamic Changes of CD127 Expressing CD8+ Effector Memory and Terminal Effector Subsets in Head and Neck Squamous Cell Carcinoma Hsiang-Fong Kao, MD – The Chinese Oncology Society (COS) |
| 6 p.m. – 6:20 p.m. | The Predictive Value of Centre Tumour CD8+ T Cells in Patients with Hepatocellular Carcinoma: Comparison with Immunoscore Cheng Sun, MD, PhD – Committee for Tumor Immunology and Bio-Therapy, Chinese Society of Immunology (TIBIT, CSI) |
| 6:20 p.m. – 6:40 p.m. | Relationship between the Peripheral Immune Profile and Tumour Antigen T Cell Responses in Breast Cancer Patients Christopher Shipp, PhD – Progress in Vaccination against Cancer (PIVAC) |
| 6:40 p.m. – 7 p.m. | Immunoscore/Immunoprofiling in Melanoma Gabriele Madonna, PhD – Società Campana di ImmunoTerapia Oncologica (SCITO) |
| 7 p.m. – 7:10 p.m. | Break |
Session IV: Therapy/Treatment |
|
|
Co-Chairs |
|
| 7:10 p.m. – 7:30 p.m. | Clinical Application of Immunotherapy – ATTACK Trials Vanessa Clay, MBChB – Adoptive Engineered T Cell Trials to Achieve Cancer Killing (ATTACK) |
| 7:30 p.m. – 7:50 p.m. | Chimeric Antigen Receptor T Cells for Hematological Tumors: Beyond CART-19 Marco Ruella, MD – The Society for Immunotherapy of Cancer |
| 7:50 p.m. – 8:10 p.m. | Prognostic Significance of Peripheral Blood Cell Counts in Melanoma Patients Chiara Martinoli, PhD – European Institute of Oncology |
| 8:10 p.m. – 8:30 p.m. | Ipilimumab Treatment Results in CD4 T Cell Activation that is Concomitant with a Reduction in Tregs and MDSCs Yago Pico de Coana, PhD – Scandinavian Network for Immunotherapy of Cancer (SNIC) |
Save the Date!
Save the dates for SITC 2016!
November 9 – 13, 2016
Gaylord National Hotel & Convention Center, National Harbor, Maryland
Thank You, Supporters!
Thank you, SITC 2015 supporters. Because of your generosity, SITC 2015 was a great success!
Interested in supporting other SITC programs? Confirm your support today!
Connect with SITC!